Meeting Banner
Abstract #0502

Using MRI to Track SPIO-Labeled Effector and Regulatory Immune Cells in a Cancer Model

Kimberly Brewer1, 2, Christa Davis3, Iulia Dude3, Genevieve Weir1, Olivia Stanley3, Mohan Karkada1, Marc Mansour1, Chris Bowen, 23

1Immunovaccine Inc., Halifax, NS, Canada; 2Biomedical Engineering, Dalhousie University, Halifax, NS, Canada; 3Institute for Biodiagnostics (Atlantic), Halifax, NS, Canada

A growing area of interest in cancer research is the behaviour of regulatory cells such as myeloid derived suppressor cells and regulatory T cells. These cells suppress both inherent and induced immune responses (i.e. via treatments such as immunotherapies) resulting in the underperformance of many anti-cancer treatments. Our current work used MRI to investigate the migration patterns of three types of SPIO-labeled immune cells in a mouse tumor model. The objectives of this study were to demonstrate reliable homing of regulatory and effector cells to tumors and lymph nodes, and observe changes in these patterns in response to cancer immunotherapy.

Keywords

active although amount anti appear approximately assess beginning biomedical cancer cell cells cervical clear cleared clots coil cologne combined concentrated concentration consistent cytotoxic days delivered derived detection developing difficulty draining effective effector efficiency engineering evaluated evidence exhibited experiment fewer field flank flow formation frequencies gradient growing highly home homing immune implantation impractical in vivo induced ingestion inguinal inherent injected injection institute intravenous iron isolated isolation isotropic label labeled labeling least loaded long lymph macrophages magnet major matrix mice migrated migration million minutes model monitored mostly mouse much node nodes none novel objectives often ongoing oxide panel panning passive patterns post potential previously probably progression pure reasonably receive recruitment reduce regulatory reliable remain required response revealed scientific seeing significantly since site sites spleens subset success successfully sufficient suppressor table terminated therapeutic throughout torso track transmit treatment treatments true tumor tumors types understanding undertake underwent vaccinated vaccination vaccine valuable viability viewing visible vitro weeks weir